medicines
Scientific Online Resource System

Annual for Hospital Pharmacy

Annual for Hospital Pharmacy

A scientific publication of the Professional Organization of Hospital Pharmacists in Bulgaria (POHPB). It presents the problems and specificity of the hospital pharmacist's work to the pharmaceutical community. The journal publishes historical, theoretical and practical materials related to the hospital pharmacy in Bulgaria, Europe, and the world. In addition to this, in each issue, the editorial board introduces the numerous readers to the achievements of foreign specialists through the published translated articles from the European Journal of Hospital Pharmacy. One issue is published each year.


Current Issue

Vol 10, No 1 (2024)

Cover and Contents

Cover and Content PDF
  1-4

Original Article

Extension of therapeutic indication and marketing authorization refusal – key aspects in EMA procedures during the period 2022-2024 PDF
Violeta Getova-Kolarova, Ines Hababa-Ivanova, Antonio Ivanov, Ilko Getov 5-11
Reimbursement of biomarkers in oncology: advantages and economic analysis of their application for diagnostics as part of the personalized medicine аpproach PDF
Veneta Todorova, Emilia Krapcheva, Georgi Slavchev, Slaveyko Dzhambazov, Toni Vekov 12-22
The role of medicinal products and medical devices classification systems in patient therapy management in hospitals PDF
Anita Neeva, Paola Petkova-Slavcheva, Evgeni Grigorov 23-29
Overview of the historical development and analysis of the stages of introduction of clinical pharmacy in Bulgaria PDF
Savina Elitova, Ilko Getov 30-37

Review Article

The role of the hospital pharmacist in optimizing therapy in patients with chronic myeloid leukemia PDF
Natalia Kokudeva, Violeta Getova-Kolarova, Emil Aleksov, Maria Kamusheva, Ilko Getov 38-46
A review of the fundamental principles for personalized pharmacotherapy prescribing for patients with concurrent renal and cardiac failure: the hospital pharmacist’s perspective PDF
Svetoslav Stoev, Hristina Lebanova 47-55
Main approaches for systemic treatment of unresectable malignant pleural mesothelioma PDF
Krum Kafedjiiski 56-64
Review of the economic burden of metastatic prostate cancer PDF
Konstantin Ivanov, Hristina Lebanova 65-71
Pharmacotherapy of non-small cell lung cancer with EGFR activating mutations using tyrosine kinase inhibitors: the role of hospital pharmacists in preventing drug-drug interactions in this class of medicines PDF
Ivanka Mutafova 72-89
Pharmacotherapy treatment options for advanced heart failure: a review PDF
Antoniya Kisheva, Mesut Rushid, Tanya Ivanowa, Tatyana Chalykova, Aylin Hadjiveli 90-93
|